INTRODUCTION
Cryptococcosis is a fungal infection caused by two varieties of Cryptococcus neoformans, which are divided into five serotypes:
serotypes A, D, and AD (C. neoformans var. neoformans) and serotypes
B and C (C. neoformans var. gatti).
1 Serotype A has a worldwide distribution and is found in most of Brazil; serotype D is found mainly in the Europe; and C.
neoformans var. gattii is limited to tropical and subtropical areas. 2 This fungus has a wide environmental distribution and is found in tree branches, bird feces, soil, fruit, and vegetables. 3 Low global frequency of cryptococcosis indicates that the host immune response is sufficient to prevent demonstrations in most immunocompetent patients. However, the disease has been increasingly found in immunocompromised patients, especially HIV-infected individuals.
1,2
The disease is spread mostly through inhalation of fungi, which usually cause asymptomatic pulmonary infection. However, the disease can spread through the blood, affecting preferably the central nervous system (CNS) and skin, called disseminated cryptococcosis (DC). Another portal of entry is the inoculation of the fungus via skin injury (primary cutaneous cryptococcosis -PCC). 4 To be considered a primary cutaneous disorder, the disease must have the following features: be exclusively cutaneous, have positive culture for fungus, and show absence of systemic involvement. If infection is present in one area, without CNS involvement or immunosuppression, the treatment is conducted with oral fluconazole, 400 mg/daily for 6-12 months. For cryptococcal meningitis, recommended treatment consists of a two-week induction therapy with intravenous amphotericin B, 0.7-1 mg/kg/day, followed by a consolidation phase with oral fluconazole 800mg/day for eight weeks. Thereafter, maintenance therapy with fluconazole 400 mg/ day is suggested for 6-12 months, or until immune restoration. 7 We report an unusual case of DC in an immunocompetent patient with skin lesions similar to those caused by primary cutane- 
CASE REPORT
We report a 68-year-old white male patient born and raised in Tupi (SP), rural worker, who complained about a 30-day asymptomatic lesion on his right forearm, with progressive growth and subsequent ulceration. He reported that he had handled a mortar bag two days before the lesion occurred.
The patient presented with poorly defined erythematous plaque (about 25cm in size) on the right forearm, displaying multiple nodules on the surface, some with fluctuation and discharging gelatinous secretion after puncture, and some ulcerated areas covered by crusts (Figures 1-3 ).
He also reported holocranial tension headache, of low intensity, three days before, associated with nausea and asthenia. He denied fever.
The patient revealed a personal history of chronic obstructive pulmonary disease for 10 years, with chronic use of corticosteroid inhalers. He was a smoker (100 packs/year) and ex-alcoholic. Systemic cryptococcal infection in immunocompetent patients, as in our case, is rare. Some cases of opportunistic infections have been reported in chronic users of high doses of inhaled corticosteroids, particularly pulmonary aspergillosis, but no DC report was found in the literature. 10 Despite the prolonged use of inhaled corticosteroids by our patient, we observed no immunosuppression in the immunologic research.
Based on our report, we question, therefore, the validity of the current concept of PCC and DC as different entities. Our patient lived in the rural area, was apparently immunocompetent, and presented with a lesion on an exposed area, features suggestive of PCC. However, the presence of meningitis defined the diagnosis of 
